Path A: ask about a registered study
ClinicalTrials.gov listed cagrilintide studies with U.S. sites in September 2026. Each registered study has an ID number that begins with NCT and a page that names the organization responsible and the study locations.
A ClinicalTrials.gov page does not promise that you will be accepted, paid, or medically suited to the study. It gives you a public record to compare with what a recruiter says.
Path B: discuss approved choices
A licensed clinician can discuss the health goal behind the search and the approved medicines that may or may not fit. Semaglutide is one ingredient with approved products; cagrilintide is not.
Compassionate use is narrow
The FDA has a pathway sometimes called compassionate use. It can let some patients with a serious or immediately life-threatening condition receive an experimental drug outside a trial when joining a trial is not possible. No such program for cagrilintide was listed on September 28, 2026.
What an honest visit cannot promise
- An approved cagrilintide prescription today.
- A pharmacy-made cagrilintide product.
- A guaranteed place in a research study.
Chapter recap
For cagrilintide itself, the public route is research. For treatment, the honest conversation is about approved options.